AGENDA
AGENDA
12:00 – 15:30h | ALLIED HEALTH PROFESSIONALS PROGRAM- Cascade Ballroom |
12:00 – 12:15h | Welcome |
12:15 – 13:00h | Multiple Myeloma Adverse Events and Frailty Discussion – Beth Faiman |
13:00 – 13:45h | Creative Solutions to Workload Issues – A Novel Pharmacy Led Myeloma Therapy Clinic – Marina Ebied |
13:45 – 14:30h | COVID-19 Treatment in Patients with Lymphoproliferative Disorders – Alisha Shivji |
14:30 – 15:15h | Inclusion, Diversity, Equity & Accessibility (IDEA) in Oncology Patient Care – Frances Folkman |
15:15h | Concluding Remarks |
1600-1700h | Registration and CCOLD Welcome Reception- Riverview Lounge |
1700-1710h | CCOLD Opening Remarks – Dr. Wendy Lam and Dr. Laurie Sehn – Cascade Ballroom |
MYELOMA SESSION
1710-1715h | Welcome & Introductions – Chair: Dr. Wendy Lam |
1715-1735h | Role of MRD in Myeloma – Dr. Chris Venner |
1735-1755h | Management of Ultra-High Risk Myeloma – Dr. Chris Chen |
1755-1815h | Bispecific Antibodies for Myeloma- Dr. Darrell White |
1815-1835h | CART for Myeloma- Dr. Chris Venner |
1835-1855h | Front-line Treatment for Myeloma
Point: ASCT- Dr. Chris Chen |
1855-1920h | Panel Discussion – Chair: Dr. Wendy Lam, Panel: Dr. Venner, Dr. Chen, Dr. White, Dr. Sandhu |
1930h | CCOLD Opening Dinner – Alberta / New Brunswick Ballroom |
SATURDAY, MARCH, 25, 2023
0630-0700h | Breakfast – Riverview Room |
CLL SESSION
0700-0705h | Welcome and Introductions – Chair: Dr. Julie Stakiw – Cascade Ballroom |
0705-0735h | Treatment form Newly Diagnosed CLL – Dr. Matthew Davids |
0735-0805h | Treatment for Relapsed/Refractory CLL – Dr. Constantine Tam |
0805-0830h | The Value of MRD in Management of CLL in 2023 – Dr. Carolyn Owen |
0830-0900h | Richter’s Transformation in CLL – Dr. Matthew Davids |
0900-1000h | Panel Discussion – Chair: Dr. Julie Stakiw, Panel: Dr. Davids, Dr. Tam, Dr. Owen |
YOUNG INVESTIGATORS’ POSTER SESSION
1300-1645h | Reception – Young Investigators’ Poster and Oral Presentations – Riverview Room |
1645-1700h | Presentation Best Poster – Dr. Anca Prica |
LYMPHOMA SESSION
1700-1705h | Welcome and Introductions – Chair: Dr. Nathalie Johnson – Cascade Ballroom |
1705-1730h | Best of ASH – Dr. Laurie Sehn |
1730-1800h | The Promise of Bispecifics in B-cell NHL – Dr. Martin Hutchings |
1800-1830h | Waldenstroms Macroglobulinemia – Dr. Constantine Tam |
1830-1900h | Mantle Cell Lymphoma – Dr. Julie Vose |
1900h-1925h | Panel Discussion – Chair: Dr. Nathalie Johnson, Panel: Dr. Hutchings, Dr. Sehn, Dr. Tam, Dr. Vose |
1930h | Dinner – Alhambra Ballroom /Foyer |
SUNDAY MARCH 26, 2023
0630-0700h | Breakfast – Riverview Room |
LYMPHOMA SESSION
0700-0705h | Welcome and Introductions – Dr. Anca Prica – Cascade Ballroom |
0705-0730h | Lymphoma Classification Systems: What You Need to Know – Dr. Julie Vose |
0730-0800h | Relapsed Refractory DLBCL – Dr. Jeremy Abramson |
0800-0840h | Debate: |
Bispecifics Should be 3rd Line Treatment for DLBCL –Dr. Martin Hutchings | |
CART Should be 3rd Line Treatment for DLBCL- Dr. Jeremy Abramson | |
0840-0905h | Maintenance Therapy in B-cell Lymphomas: What to Keep, What to Abandon?- Dr. Diego Villa |
0905h-0955h | Panel Discussion: Chair: Dr. Anca Prica, Panel: Dr. Abramson, Dr. Hutchings, Dr. Vose, Dr. Villa |
0955-1000h | Closing Remarks- Dr. Laurie Sehn and Dr. Wendy Lam |